Natural killer cell expansion

Natural killer cell expansion" refers to the process by which the number of NK cells (natural killer cells) increases, typically in the context of immune responses, immunotherapy, or cell culture. NK cells themselves are a type of cytotoxic lymphocyte important for the innate immune system, capable of killing virus-infected, stressed, or malignant cells without prior sensitization[2][3][1]. However, “expansion” is not the name of a specific molecule, receptor, or target, but a general term for augmenting cell counts, often through stimulation by cytokines like IL-2 or IL-15[6]. Because the term does not denote a discrete molecular target, it is not considered a therapeutic target on its own and is not classified as a protein, receptor, enzyme, or similar entity. The correct molecular targets relevant to NK cell expansion might include direct surface receptors on NK cells or the cytokines that promote their proliferation. In summary, "Natural killer cell expansion" should not be treated as a molecular target for drug discovery or biomedical data structuring[2][3][1]. Instead, specific targets would include NK cell surface receptors (e.g., CD56, NKG2D, NKp30, NKp44), cytokine receptors (e.g., IL-2 receptor, IL-15 receptor), or the cytokines involved in the process.